Dr. Wanzhen Zeng, a highly skilled and innovative nuclear medicine specialist, is devoted to providing precise, patient-centered diagnostic and therapeutic services that leverage advanced nuclear imaging and molecular techniques. His clinical expertise includes the use of positron emission tomography (PET) and single-photon emission computed tomography (SPECT) for accurate diagnosis and staging of cancers, cardiac perfusion imaging to assess coronary artery disease, and radionuclide therapies such as iodine-131 for thyroid disorders and lutetium-177 for neuroendocrine tumors. Dr. Zeng has a particular interest in theranostics, a cutting-edge approach that combines diagnostic imaging with targeted radionuclide therapy, offering personalized treatment options for complex conditions like metastatic prostate cancer. He is committed to integrating evidence-based practices and the latest technology to enhance patient outcomes and optimize care pathways. Share your feedback to help others discover Dr. Zeng’s exceptional expertise, clinical precision, and unwavering commitment to advancing nuclear medicine and improving the lives of his patients.